-
1
-
-
0026457634
-
Serial cranial and spinal cord magnetic resonance imaging in multiple sclerosis
-
Wiebe S, Lee DH, Karlik SJ, et al. Serial cranial and spinal cord magnetic resonance imaging in multiple sclerosis. Ann Neurol 1992;32:643-650.
-
(1992)
Ann Neurol
, vol.32
, pp. 643-650
-
-
Wiebe, S.1
Lee, D.H.2
Karlik, S.J.3
-
2
-
-
0018290191
-
National Cooperative Crohn's Disease Study: Result of drug treatment
-
Summer RW, Switz DM, Sessions JT, et al. National Cooperative Crohn's Disease Study: result of drug treatment. Gastroenterology 1979;77(part 2):847-869.
-
(1979)
Gastroenterology
, vol.77
, Issue.2 PART
, pp. 847-869
-
-
Summer, R.W.1
Switz, D.M.2
Sessions, J.T.3
-
3
-
-
0021160552
-
Sulfasalazine. Pharmacology, clinical use, toxicity, and related new drug development
-
Peppercorn MA. Sulfasalazine. Pharmacology, clinical use, toxicity, and related new drug development. Ann Intern Med 1984;101:377-386.
-
(1984)
Ann Intern Med
, vol.101
, pp. 377-386
-
-
Peppercorn, M.A.1
-
4
-
-
0022620376
-
Sulfasalazine and new analogues
-
Friedman G. Sulfasalazine and new analogues. Am J Gastroenterol 1986;81:141-144.
-
(1986)
Am J Gastroenterol
, vol.81
, pp. 141-144
-
-
Friedman, G.1
-
5
-
-
0020503084
-
Sulfasalazine in rheumatoid arthritis: A double blind comparison of sulfasalazine with placebo and sodium aurothiomalate
-
Pullar T, Hunter JA, Capell HA. Sulfasalazine in rheumatoid arthritis: a double blind comparison of sulfasalazine with placebo and sodium aurothiomalate. BMJ 1983;287:1102-1104.
-
(1983)
BMJ
, vol.287
, pp. 1102-1104
-
-
Pullar, T.1
Hunter, J.A.2
Capell, H.A.3
-
6
-
-
0022870286
-
Sulfasalazine in rheumatoid arthritis. A double-blind, placebo-controlled trial
-
Erratum. Arthritis Rheum 1987;30(4):459
-
Pinals RS, Kaplan SB, Lawson JG, Hepburn B. Sulfasalazine in rheumatoid arthritis. A double-blind, placebo-controlled trial. Arthritis Rheum 1986;29:1427-1434. Erratum. Arthritis Rheum 1987;30(4):459.
-
(1986)
Arthritis Rheum
, vol.29
, pp. 1427-1434
-
-
Pinals, R.S.1
Kaplan, S.B.2
Lawson, J.G.3
Hepburn, B.4
-
7
-
-
0023150139
-
Long-term treatment of rheumatoid arthritis with sulfasalazine, gold, or penicillamine: A comparison using life-table methods
-
Situnayake RD, Grindulis KA, McConkey B. Long-term treatment of rheumatoid arthritis with sulfasalazine, gold, or penicillamine: a comparison using life-table methods. Ann Rheum Dis 1987;46:177-183.
-
(1987)
Ann Rheum Dis
, vol.46
, pp. 177-183
-
-
Situnayake, R.D.1
Grindulis, K.A.2
McConkey, B.3
-
8
-
-
0023924884
-
A controlled trial comparing sulfasalazine, gold sodium thiomalate, and placebo in rheumatoid arthritis
-
Williams HJ, Ward JR, Dahl SL, et al. A controlled trial comparing sulfasalazine, gold sodium thiomalate, and placebo in rheumatoid arthritis. Arthritis Rheum 1988;31:702-713.
-
(1988)
Arthritis Rheum
, vol.31
, pp. 702-713
-
-
Williams, H.J.1
Ward, J.R.2
Dahl, S.L.3
-
9
-
-
0024604643
-
Effects of hydroxychloroquine and sulfasalazine on progression of joint damage in rheumatoid arthritis
-
van der Heijde DM, van Riel PL, Nover-Zwart IH, Gribnau FW, van De Putte LB. Effects of hydroxychloroquine and sulfasalazine on progression of joint damage in rheumatoid arthritis. Lancet 1989;1(8646):1036-1038.
-
(1989)
Lancet
, vol.1
, Issue.8646
, pp. 1036-1038
-
-
Van Der Heijde, D.M.1
Van Riel, P.L.2
Nover-Zwart, I.H.3
Gribnau, F.W.4
Van De Putte, L.B.5
-
10
-
-
0024559181
-
A double-blind comparative study of sulfasalazine and hydroxychloroquine in rheumatoid arthritis: Evidence of an earlier effect of sulfasalazine
-
Nuver-Zwart IH, van Riel PL, van de Pul, Gribnau FW. A double-blind comparative study of sulfasalazine and hydroxychloroquine in rheumatoid arthritis: evidence of an earlier effect of sulfasalazine. Ann Rheum Dis 1989;48:389-395.
-
(1989)
Ann Rheum Dis
, vol.48
, pp. 389-395
-
-
Nuver-Zwart, I.H.1
Van Riel, P.L.2
Van De Pul3
Gribnau, F.W.4
-
11
-
-
0024151212
-
Treatment of psoriatic arthritis with sulfasalazine: A one-year open study
-
Farr M, Kitas GD, Waterhouse L, Jubb R, Felix Davies D, Bacon PA. Treatment of psoriatic arthritis with sulfasalazine: a one-year open study. Clin Rheumatol 1988;7:372-377.
-
(1988)
Clin Rheumatol
, vol.7
, pp. 372-377
-
-
Farr, M.1
Kitas, G.D.2
Waterhouse, L.3
Jubb, R.4
Felix Davies, D.5
Bacon, P.A.6
-
12
-
-
0344400614
-
Sulphasalazine in psoriatic arthritis
-
Abstract
-
Fraser S, Capell HA, Hunter JA, Hopkins R, Bird HA. Sulphasalazine in psoriatic arthritis. Br J Rheumatol 1988;27:49. Abstract.
-
(1988)
Br J Rheumatol
, vol.27
, pp. 49
-
-
Fraser, S.1
Capell, H.A.2
Hunter, J.A.3
Hopkins, R.4
Bird, H.A.5
-
13
-
-
0022505615
-
Sulphasalazine in ankylosing spondylitis: A double blind controlled study in 60 patients
-
Dougados M, Boumier P, Amor B. Sulphasalazine in ankylosing spondylitis: a double blind controlled study in 60 patients. BMJ 1986;293:911-914.
-
(1986)
BMJ
, vol.293
, pp. 911-914
-
-
Dougados, M.1
Boumier, P.2
Amor, B.3
-
14
-
-
0022573073
-
Sulphasalazine in ankylosing spondylitis
-
Feltelius N, Hallgren R. Sulphasalazine in ankylosing spondylitis. Ann Rheum Dis 1986;45:396-399.
-
(1986)
Ann Rheum Dis
, vol.45
, pp. 396-399
-
-
Feltelius, N.1
Hallgren, R.2
-
15
-
-
0023739922
-
Sulfasalazine in the treatment of ankylosing spondylitis. A twenty-six-week, placebo-controlled clinical trial
-
Nissila M, Lehtinen K, Leirisalo-Repo M, Luukkainen R, Mutru O, Yli-Kerttula U. Sulfasalazine in the treatment of ankylosing spondylitis. A twenty-six-week, placebo-controlled clinical trial. Arthritis Rheum 1988;31:1111-1116.
-
(1988)
Arthritis Rheum
, vol.31
, pp. 1111-1116
-
-
Nissila, M.1
Lehtinen, K.2
Leirisalo-Repo, M.3
Luukkainen, R.4
Mutru, O.5
Yli-Kerttula, U.6
-
17
-
-
0024339840
-
Suppression of experimental autoimmune encephalitis by sulfasalazine
-
Letter
-
Prosiegel M, Neu I, Ruhenstroth Bauer G, et al. Suppression of experimental autoimmune encephalitis by sulfasalazine. N Engl J Med 1989;321:545-546. Letter.
-
(1989)
N Engl J Med
, vol.321
, pp. 545-546
-
-
Prosiegel, M.1
Neu, I.2
Ruhenstroth Bauer, G.3
-
18
-
-
0025320782
-
Suppression of experimental autoimmune encephalomyelitis by sulfasalazine
-
Prosiegel M, Neu I, Vogl S, Hoffmann G, Wildfeuer A, Ruhenstroth Bauer G. Suppression of experimental autoimmune encephalomyelitis by sulfasalazine. Acta Neurol Scand 1990;81:237-238.
-
(1990)
Acta Neurol Scand
, vol.81
, pp. 237-238
-
-
Prosiegel, M.1
Neu, I.2
Vogl, S.3
Hoffmann, G.4
Wildfeuer, A.5
Ruhenstroth Bauer, G.6
-
19
-
-
0022541706
-
Pharmacological and biochemical actions of sulphasalazine
-
Hoult JR. Pharmacological and biochemical actions of sulphasalazine. Drugs 1986;32:18-26.
-
(1986)
Drugs
, vol.32
, pp. 18-26
-
-
Hoult, J.R.1
-
20
-
-
0023259567
-
The antiinflammatory moiety of sulfasalazine, 5-aminosalicylic acid, is a radical scavenger
-
Ahnfelt-Ronne I, Nielsen OH. The antiinflammatory moiety of sulfasalazine, 5-aminosalicylic acid, is a radical scavenger. Agents Actions 1987;21:191-194.
-
(1987)
Agents Actions
, vol.21
, pp. 191-194
-
-
Ahnfelt-Ronne, I.1
Nielsen, O.H.2
-
21
-
-
0023552738
-
Sulfasalazine and related new drugs
-
Peppercorn MA. Sulfasalazine and related new drugs. J Clin Pharmacol 1987;27:260-266.
-
(1987)
J Clin Pharmacol
, vol.27
, pp. 260-266
-
-
Peppercorn, M.A.1
-
22
-
-
0023913191
-
In vitro immunomodulatory effects of sulfasalazine and its metabolites
-
Comer SS, Jasin HE. In vitro immunomodulatory effects of sulfasalazine and its metabolites. J Rheumatol 1988;15:580-586.
-
(1988)
J Rheumatol
, vol.15
, pp. 580-586
-
-
Comer, S.S.1
Jasin, H.E.2
-
23
-
-
0021035886
-
Rating neurological impairment in multiple sclerosis: An Expanded Disability Status Scale (EDSS)
-
Kurtzke JF. Rating neurological impairment in multiple sclerosis: an Expanded Disability Status Scale (EDSS). Neurology 1983;33:1444-1452.
-
(1983)
Neurology
, vol.33
, pp. 1444-1452
-
-
Kurtzke, J.F.1
-
24
-
-
0027418515
-
Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial
-
The IFBN Multiple Sclerosis Study Group. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. Neurology 1993;43:655-661.
-
(1993)
Neurology
, vol.43
, pp. 655-661
-
-
-
25
-
-
0027521002
-
Interferon beta-lb is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial
-
Paty DW, Li DKB, The University of British Columbia MS/ MRI Analysis Group, The IFBN Multiple Sclerosis Study Group. Interferon beta-lb is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. Neurology 1993;43:662-667.
-
(1993)
Neurology
, vol.43
, pp. 662-667
-
-
Paty, D.W.1
Li, D.K.B.2
-
26
-
-
0029161628
-
Interferon β-1b in the treatment of MS: Final outcome of the randomized controlled trial
-
The IFBN Multiple Sclerosis Study Group, The University of British Columbia MS/MRI Analysis Group. Interferon β-1b in the treatment of MS: final outcome of the randomized controlled trial. Neurology 1995;45:1277-1285.
-
(1995)
Neurology
, vol.45
, pp. 1277-1285
-
-
-
27
-
-
0008678962
-
Intramuscular interferon beta-la for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)
-
Jacobs LD, Cookfair DL, Rudick RA, et al. Intramuscular interferon beta-la for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG). Ann Neurol 1996;39:285-294.
-
(1996)
Ann Neurol
, vol.39
, pp. 285-294
-
-
Jacobs, L.D.1
Cookfair, D.L.2
Rudick, R.A.3
-
28
-
-
8544249096
-
Impact of interferon beta-1a on neurologic disability in relapsing multiple sclerosis
-
Rudick R, Goodkin D, Jacobs L, et al. Impact of interferon beta-1a on neurologic disability in relapsing multiple sclerosis. Neurology 1997;49:358-363.
-
(1997)
Neurology
, vol.49
, pp. 358-363
-
-
Rudick, R.1
Goodkin, D.2
Jacobs, L.3
-
29
-
-
6844250787
-
Magnetic resonance studies of intramuscular interferon b-1a for relapsing multiple sclerosis
-
Simon J, Jacobs L, Campion M, et al. Magnetic resonance studies of intramuscular interferon b-1a for relapsing multiple sclerosis. Neurology 1998;43:79-87.
-
(1998)
Neurology
, vol.43
, pp. 79-87
-
-
Simon, J.1
Jacobs, L.2
Campion, M.3
-
30
-
-
0029082566
-
Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: Results of a phase III multicenter, double-blind placebo-controlled trial. The Copolymer 1 Multiple Sclerosis Study Group
-
Johnson KP, Brooks BR, Cohen JA, et al. Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind placebo-controlled trial. The Copolymer 1 Multiple Sclerosis Study Group [see comments]. Neurology 1995;45:1268-1276.
-
(1995)
Neurology
, vol.45
, pp. 1268-1276
-
-
Johnson, K.P.1
Brooks, B.R.2
Cohen, J.A.3
-
31
-
-
6844254570
-
Extended use of galtiramer acetate (Copaxone) is well tolerated and maintains its clinical effect on multiple sclerosis relapse rate and degree of disability
-
Johnson KP, Brooks BR, Cohen JA, et al. Extended use of galtiramer acetate (Copaxone) is well tolerated and maintains its clinical effect on multiple sclerosis relapse rate and degree of disability. Neurology 1998;50:701-708.
-
(1998)
Neurology
, vol.50
, pp. 701-708
-
-
Johnson, K.P.1
Brooks, B.R.2
Cohen, J.A.3
-
32
-
-
0020686503
-
New diagnostic criteria for multiple sclerosis: Guidelines for research protocols
-
Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13:227-231.
-
(1983)
Ann Neurol
, vol.13
, pp. 227-231
-
-
Poser, C.M.1
Paty, D.W.2
Scheinberg, L.3
-
33
-
-
0026844653
-
Inter- and intrarater scoring agreement using grades 1.0 to 3.5 of the Kurtzke Expanded Disability Status Scale (EDSS)
-
Multiple Sclerosis Collaborative Research Group
-
Goodkin DE, Cookfair D, Wende K, et al. Inter- and intrarater scoring agreement using grades 1.0 to 3.5 of the Kurtzke Expanded Disability Status Scale (EDSS). Multiple Sclerosis Collaborative Research Group. Neurology 1992;42:859-863.
-
(1992)
Neurology
, vol.42
, pp. 859-863
-
-
Goodkin, D.E.1
Cookfair, D.2
Wende, K.3
-
34
-
-
0020683886
-
Intensive immunosuppression in progressive multiple sclerosis. A randomized, three-arm study of high-dose intravenous cyclophosphamide, plasma exchange, and ACTH
-
Hauser SL, Dawson DM, Lehrich JR, et al. Intensive immunosuppression in progressive multiple sclerosis. A randomized, three-arm study of high-dose intravenous cyclophosphamide, plasma exchange, and ACTH. N Engl J Med 1983;308:173-180.
-
(1983)
N Engl J Med
, vol.308
, pp. 173-180
-
-
Hauser, S.L.1
Dawson, D.M.2
Lehrich, J.R.3
-
35
-
-
0028390325
-
Computer-assisted identification and quantification of multiple sclerosis lesions in MR imaging volumes in the brain
-
Mitchell JR, Karlik SJ, Lee DH, Fenster A. Computer-assisted identification and quantification of multiple sclerosis lesions in MR imaging volumes in the brain. J Magn Reson Imaging 1994;4:197-208.
-
(1994)
J Magn Reson Imaging
, vol.4
, pp. 197-208
-
-
Mitchell, J.R.1
Karlik, S.J.2
Lee, D.H.3
Fenster, A.4
-
36
-
-
0002238899
-
Comparing two samples: Extensions of the t, rank-sum, and log-rank tests
-
O'Brien PC. Comparing two samples: extensions of the t, rank-sum, and log-rank tests. J Am Stat Assoc 1988;83:52-61.
-
(1988)
J Am Stat Assoc
, vol.83
, pp. 52-61
-
-
O'Brien, P.C.1
-
37
-
-
0018687930
-
A multiple-testing procedure for clinical trials
-
O'Brien PC, Fleming TR. A multiple-testing procedure for clinical trials. Biometrics 1979;35:549-556.
-
(1979)
Biometrics
, vol.35
, pp. 549-556
-
-
O'Brien, P.C.1
Fleming, T.R.2
-
38
-
-
0029913882
-
Defining the clinical course of multiple sclerosis: Results of an international survey
-
Lublin FD, Reingold SC, for the National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Defining the clinical course of multiple sclerosis: results of an international survey. Neurology 1996;46:907-911.
-
(1996)
Neurology
, vol.46
, pp. 907-911
-
-
Lublin, F.D.1
Reingold, S.C.2
-
39
-
-
0026551688
-
The use of subjective rankings in clinical trials with an application to cardiovascular disease
-
Follmann D, Wittes J, Cutler JA. The use of subjective rankings in clinical trials with an application to cardiovascular disease. Stat Med 1992;11:427-437.
-
(1992)
Stat Med
, vol.11
, pp. 427-437
-
-
Follmann, D.1
Wittes, J.2
Cutler, J.A.3
-
40
-
-
0344832127
-
Are placebo-controlled trials still ethical in multiple sclerosis?
-
Thompson A, Polman C, Hohlfeld R, eds. London: Martin Dunitz
-
Noseworthy J. Are placebo-controlled trials still ethical in multiple sclerosis? In: Thompson A, Polman C, Hohlfeld R, eds. A problem-oriented approach to management and treatment of multiple sclerosis. London: Martin Dunitz, 1997:177-193.
-
(1997)
A Problem-oriented Approach to Management and Treatment of Multiple Sclerosis
, pp. 177-193
-
-
Noseworthy, J.1
|